Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept and Abatacept in Rheumatoid Arthritis
NCT00279760Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Primary completion
- Mar 2002
- Modality
- Fc-Fusion Proteins
- Countries
- 9
01
Overview
A Phase 2 trial of belatacept, abatacept in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Status: completed.
02
Drugs
belataceptabatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00279760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00279760.